Unknown

Dataset Information

0

ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2? kinases.


ABSTRACT: ONC201 (also called TIC10) is a small molecule that inactivates the cell proliferation- and cell survival-promoting kinases Akt and ERK and induces cell death through the proapoptotic protein TRAIL. ONC201 is currently in early-phase clinical testing for various malignancies. We found through gene expression and protein analyses that ONC201 triggered an increase in TRAIL abundance and cell death through an integrated stress response (ISR) involving the transcription factor ATF4, the transactivator CHOP, and the TRAIL receptor DR5. ATF4 was not activated in ONC201-resistant cancer cells, and in ONC201-sensitive cells, knockdown of ATF4 or CHOP partially abrogated ONC201-induced cytotoxicity and diminished the ONC201-stimulated increase in DR5 abundance. The activation of ATF4 in response to ONC201 required the kinases HRI and PKR, which phosphorylate and activate the translation initiation factor eIF2?. ONC201 rapidly triggered cell cycle arrest, which was associated with decreased abundance of cyclin D1, decreased activity of the kinase complex mTORC1, and dephosphorylation of the retinoblastoma (Rb) protein. The abundance of X-linked inhibitor of apoptosis protein (XIAP) negatively correlated with the extent of apoptosis in response to ONC201. These effects of ONC201 were independent of whether cancer cells had normal or mutant p53. Thus, ONC201 induces cell death through the coordinated induction of TRAIL by an ISR pathway.

SUBMITTER: Kline CL 

PROVIDER: S-EPMC4968406 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7588802 | BioStudies
2015-01-01 | S-EPMC4537643 | BioStudies
1000-01-01 | S-EPMC5400611 | BioStudies
1000-01-01 | S-EPMC4614396 | BioStudies
2015-01-01 | S-EPMC4541796 | BioStudies
1000-01-01 | S-EPMC5071577 | BioStudies
2020-01-01 | S-EPMC7584235 | BioStudies
2017-01-01 | S-EPMC6117120 | BioStudies
2016-01-01 | S-EPMC5023178 | BioStudies
2016-01-01 | S-EPMC4815038 | BioStudies